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Summary
Moyamoya disease is characterized by bilateral stenosis
and/or occlusion of the terminal portion of the internal
carotid artery. Moyamoya disease is prevalent among
patients !10 years of age. Although most cases appear
to be sporadic, ∼10% occur as familial cases. The in-
cidence of familial cases has been increasing because
noninvasive diagnostic equipment, such as magnetic-res-
onance imaging and magnetic-resonance angiography,
can detect the disease in almost all affected patients,
including asymptomatic patients, during screening stud-
ies. In this study, we performed a total genome search
to identify the location of a familial moyamoya disease
gene in 16 families, assuming an unknown mode of in-
heritance. A linkage was found between the disease and
markers located at 3p24.2-26. A maximum NPL score
of 3.46 was obtained with marker D3S3050. This is the
first genetic locus found to be involved in the molecular
pathogenesis of familial moyamoya disease.
Introduction
Spontaneous occlusion of the circle of Willis, first de-
scribed as “moyamoya disease” (MIM 252350) in Japan
(Suzuki and Takaku 1969), is characterized by bilateral
stenosis and/or occlusion of the terminal portion of the
internal carotid artery and by the development of ab-
normal netlike vessels at the base of the brain. A high
incidence of moyamoya disease occurs in Asia, especially
in Japan (Ikezaki et al. 1997). Moyamoya disease is not
associated with any location of unusually high incidence
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in Japan (Goto and Yonekawa 1992). Moyamoya dis-
ease occurs more frequently in females (male-to-female
ratio of 2:3) and is prevalent among patients !10 years
of age (Suzuki 1983). Juvenile patients with moyamoya
disease initially present with transient motor distur-
bances—that is, symptoms of transient brain ische-
mia—whereas adults present with intracranial hemor-
rhage. The symptoms in juvenile patients are due to the
narrowing or occlusion of the circle of Willis, and those
in adults are due to a collapse of collateral circulation,
which gradually develops as a result of the occlusion of
the carotid fork at a younger age.
Most cases of moyamoya disease appear to be spo-
radic, but ∼10% are familial cases (Fukuyama et al.
1991; Fukui 1997). Approximately 70% of cases of
moyamoya disease among family members occur in sib-
lings, and 24% occur in a parent and offspring (Fuku-
yama et al. 1991). The incidence of such familial cases
has been increasing because noninvasive diagnostic
equipment, such as magnetic-resonance imaging (MRI)
and magnetic-resonance angiography (MRA), can detect
the disease in almost 100% of affected patients, includ-
ing asymptomatic patients, during screening studies (Ike-
zaki et al. 1997). Therefore, extensive genetic study of
moyamoya disease has become urgent and important,
although moyamoya disease has long been thought to
be caused mainly by environmental factors (Suzuki
1983). In this study, we tried to identify the locus as-
sociated with moyamoya disease, by performing a ge-
nomewide search with genotypes of microsatellite poly-
morphic markers.
Subjects and Methods
Family Pedigree and DNA Extraction
We studied 77 Japanese individuals (28 males and 49
females) in 16 families with 3–13 members (fig. 1). No
history of intermarriage was evident. Moyamoya disease
was detected in 37 of the 77 individuals, on the basis
of the guidelines for the diagnosis of moyamoya disease
set by the Research Committee on Spontaneous Occlu-
sion of the Circle of Willis of the Ministry of Health and
534 Am. J. Hum. Genet. 64:533–537, 1999
Figure 1 Pedigrees of the families with moyamoya disease. All
individuals shown were genotyped, except those who are deceased and
those marked with an asterisk (*). Blackened squares and circles in-
dicate individuals with moyamoya disease , and unblackened symbols
indicate normal individuals. The mean age at diagnosis was 12 years.
Welfare of Japan (Ikezaki et al. 1997). These guidelines
require diagnosis, by MRA and MRI, of both of the
following specific findings: (1) bilateral narrowing or
stenosis of the carotid fork, detected by MRA, and (2)
abnormal vascular networks in the bilateral basal gan-
glia, detected by MRI as more than two flow voids in
each brain hemisphere. Two of the 37 patients were
asymptomatic and were identified by chance during
MRA screening.
Genomic DNA was extracted from the peripheral
blood of 22 individuals in 3 families (both affected and
unaffected individuals were analyzed) and also from 55
blood samples (from 13 families) generously supplied by
the blood bank holding blood samples from individuals
with moyamoya disease. The DNA was prepared from
the blood samples by proteinase K digestion and the
phenol-chloroform–extraction method.
Genotyping
Genotyping for 371 highly polymorphic microsatellite
markers spanning the 22 autosomes was performed by
use of the Weber human linkage screening set, version
6 (Research Genetics). One marker on chromosome 3p
(3D1560; The Genome Database [GDB] accession num-
ber 238670) was added. The spacing between adjacent
markers was 7–20 cM, and the mean heterozygosity of
the markers was 76%. PCR was performed with 50-ml
mixtures (pH 8.4 or 8.6) of 100 ng genomic DNA, 200
mM dATP, 200 mM dTTP, 200 mM dGTP, 20 mM dCTP,
20 pmol of each primer, 0.5 U Taq polymerase, 1.0–2.5
mMMgCl2, 50 mM KCl, and 0.1 mCi a[
32P]-dCTP. PCR
amplifications were performed in a PC-800 (ASTEC) by
use of the following parameters: initial denaturation at
94C for 5 min, followed by 35 cycles (94C for 1 min
30 s, 52C–60C for 1 min 30 s, and 71C for 2 min)
and a final elongation at 71C for 5 min. The annealing
temperature was optimized for each set of primers. The
PCR-amplified product solution was used for electro-
phoresis loading (80 W for 2–3 h at constant power) on
a 6% polyacrylamide gel. Autoradiography was per-
formed by exposure of the film, at 80C, for 2–72 h.
Initially, eight families (pedigrees 1–8) were used to
screen for any locus suggestive of linkage. Then, eight
more families (pedigrees 9–16) were included, to analyze
the region of interest.
Linkage Analysis
To screen the loci suspected to be responsible for moy-
amoya disease, two-point LOD scores were calculated,
under the assumption of either autosomal recessive in-
heritance or autosomal dominant inheritance (incom-
plete penetrance), by use of the MLINK program as
implemented in the LINKAGE package, version 5.20
(Terwilliger and Ott 1994). Full multipoint calculations
for nonparametric analysis were determined, by use of
the GENEHUNTER program (Lander and Kruglyak
1995), because nonparametric analysis provides a robust
significance of linkage irrespective of the mode of in-
heritance. The penetrance of the familial disease was
estimated to be nearly 100%. The disease-allele fre-
quency chosen was .000035, on the basis of the 1994
annual report of the Research Committee on Sponta-
neous Occlusion of the Circle of Willis of the Ministry
of Health and Welfare of Japan (Fukui 1996, p. 36).
Allele frequencies of the markers were obtained from the
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Table 1
NPL Scores Obtained by Nonparametric Linkage Analysis at
3p24.2-p25
Locus and




.00 2.79470 .002527 .887136
1.67 2.89951 .001819 .758705
3.34 3.01797 .001225 .708900
5.02 3.15065 .000745 .702517
6.69 3.29816 .000459 .739142
D3S3050:
8.36 3.46119 .000238 .850934
9.48 3.35205 .000360 .752518
10.60 3.24986 .000527 .717286
11.72 3.15447 .000738 .716760
12.84 3.06571 .001049 .750260
D3S1304:
13.96 2.98345 .001345 .842207
14.71 2.77165 .002805 .745647
15.46 2.57414 .004968 .701351
16.21 2.39063 .008511 .686057
D3S1304:
16.95 2.22085 .013161 .699786
17.70 2.06458 .019914 .765910
a Distance is from top of chromosome 3.
GDB, and markers on chromosome 3p24.2-p26 were
determined on the basis of samples of DNA from 50
normal Japanese subjects.
Results
For the initial screening of eight families, we used all
the markers on chromosomes 1–22. Linkage analysis
under the assumption of autosomal recessive inheritance
revealed that the D3S2387 (The Cooperative Human
Linkage Center [CHLC] accession number 31795) and
D3S3050 (CHLC accession number 41102) loci on chro-
mosome 3 showed LOD scores 11.0, whereas LOD
scores were !1.0 for the rest of the markers. The LOD
score for D3S2387 was 1.493576 at a recombination
fraction (v) of .1 (nonparametric LOD [NPL] score 2.31,
information content .848), and that for D3S3050 was
3.184154 at (NPL score 1.80, information con-v  .01
tent .892). Nonparametric linkage analysis showed an
NPL score 11.96 at loci between D3S2387 andD3S3050
and an information content of .785–.892. These two
loci are both on chromosome 3p24.2-p26.
For the study of the eight additional families, we used
four markers (D3S2387, D3S3050, D3S1560, and
D3S1304 [GDB 62981]) at 3p24.2-p26. Nonparametric
analysis revealed a significant linkage at marker
D3S3050 (NPL score 3.46, information content .851;
table 1).
Discussion
Moyamoya disease is a rare cerebrovascular disorder
of unknown etiology. There are two major hypotheses
concerning the etiology of moyamoya disease—namely,
that it is a genetically inherited disease or that it is an
acquired disease. The latter etiology includes infection,
such as laryngitis, and has been thought to induce an
autoimmune response against some components of the
circle of Willis, resulting in specific angiitis (Suzuki
1983). However, there is no definite evidence that in-
fections can actually induce moyamoya disease. Certain
environmental agents are also suspected to be the cause
of acquired disease. However, a massive case-control
study has revealed no positive linkage with environ-
mental agents (Fukui 1997). An epidemiological study
(Graham and Matoba 1997) showed that moyamoya
disease in Hawaii has a higher incidence and prevalence
than in the rest of the United States, mostly owing to
the larger percentage of Asians, particularly Japanese,
living in Hawaii, which suggests that moyamoya disease
is caused by genetic, rather than environmental, factors.
In Japan, no special incidence of moyamoya disease has
been linked with occupation, lifestyle, or site of resi-
dence. Such evidence strongly suggests that environ-
mental factors are not important in the development of
moyamoya disease.
The prominent histological change of the bilateral ca-
rotid forks that is associated with moyamoya disease is
an eccentric fibrosis, or cellular-fibrous thickening, of the
intima. The internal elastic lamina shows tortuosity and
duplication, whereas the media shows atrophy and thin-
ning. The adventitia does not showmarked change (Oka
1981; Suzuki 1983; Ikeda 1991). In general, these af-
fected vessels do not show arteriosclerotic or inflam-
matory changes. The most severely affected site is con-
fined to the carotid fork, and the lesion usually is
bilateral. Histologically, the vessel wall is narrowed or
obstructed by eccentric proliferation of the endothelium,
which is composed of several laminated elastic lamina
intermingled with fibrosis. A whole-body–autopsy study
of patients with moyamoya disease, aged 6–58 years
(mean 37 years), showed that 32 of 36 patients had
several abnormal changes in arteries other than those in
the brain that were similar to changes found in the af-
fected cerebral vessels. Such systemic vascular changes
included intimal hypertrophy of the renal, coronary,
pancreatic, and pulmonary arteries (Suzuki 1983; Ikeda
1991).Morphometric analysis (Ikeda 1991) revealed sig-
nificant intimal thickening of the pulmonary arteries,
renal arteries, and pancreatic arteries in patients with
moyamoya disease, compared with age- and sex-
matched controls. Thus, the pathological lesion of this
disease is not localized but is systemic, and it is not
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formed by the inflammatory or aging process (Ikeda
1991). These histopathological findings strongly suggest
that the lesion is formed by a progressive and continuous
process and that the most susceptible site, which may
be genetically determined, is the bilateral carotid fork.
Therefore, moyamoya disease can be regarded as a se-
vere intracranial manifestation of systemic arterial dis-
ease, and it is triggered by a noninflammatory, nonar-
teriosclerotic, eccentric thickening of the intima of the
bilateral carotid fork.
These pathologic and epidemiological facts suggest
that genetic factors play a more important role in the
pathogenesis of moyamoya disease than do acquired fac-
tors. Recently, a hypothesis accounting for the intimal
thickening proposed that abnormal regulation of extra-
cellular-matrix (ECM)metabolismmay lead to increased
steady-state levels of elastin mRNA and elastin accu-
mulation in arterial smooth-muscle cells (SMCs) in pa-
tients with moyamoya disease (Yamamoto et al. 1997).
Such intrinsic abnormalities of SMCs in patients with
moyamoya disease also suggest that the pathogenesis of
moyamoya disease is genetically determined. The gene
for a second form of Marfan syndrome (MIM 154700),
a connective-tissue disorder characterized by skeletal
and cardiovascular anomalies, also may be located on
chromosome 3p25-24.2 (Collod et al. 1994). Elastin and
collagen are the major components of the ECM, and
congenital vascular defects or abnormalities tend to re-
sult from defects in these structural proteins. The fact
that both moyamoya disease, which is presumably
caused by disturbance of the ECM, and the fibrous–
connective-tissue disorder Marfan syndrome have been
mapped to the same region of the chromosome is note-
worthy.
Investigation of the mode of inheritance of moyamoya
disease is complicated by the variety of symptoms caused
by this disease. The diagnosis of moyamoya disease
depends on only the finding of bilateral carotid angio-
graphy. The initial symptoms of moyamoya disease are
transient brain ischemia, caused by the narrowing and/
or obstruction of the carotid fork, before 10 years of
age. Progressive narrowing of the carotid fork results in
gradual development of collateral circulation, which is
detected, by carotid angiography, as an abnormal vas-
cular network. Eventual rupture of the abnormal vessels
results in symptoms of intracranial hemorrhage, after 30
years of age. Therefore, although the symptoms are dif-
ferent in the adult and juvenile types of the disease, both
types are considered to be different aspects of a single
process at different times in the course of the disease. In
particular, the severity of the clinical symptoms has no
significant correlation with the degree of angiographical
stenosis of the carotid fork. Thus, genetic heterogeneity
in moyamoya disease is difficult to identify from the
symptomatology. Also, cases of moyamoya disease prob-
ably exist among the healthy population, owing to de-
layed consultation of a physician because the symptoms
in childhood are mild and transient. Even if juvenile
patients mature to adulthood without a diagnosis of
moyamoya disease, identification remains difficult unless
the fragile collateral vessels are ruptured, especially since
the asymptomatic period of affected patients can be long.
Moyamoya disease cannot be diagnosed without inva-
sive examination by bilateral carotid angiography, but
adult patients with moyamoya disease often are coma-
tose at the onset of intracranial hemorrhage, so invasive
examination is impossible. These various factors suggest
that the actual frequency of the disease allele is much
higher than the reported value of .000035, which is
based on the statistical research of the Research Com-
mittee on Spontaneous Occlusion of the Circle of Willis
of the Ministry of Health and Welfare of Japan.
We analyzed three families with affected parents and
children (pedigrees 1, 5, and 6). The initial symptoms
were intracerebral hemorrhage in all affected parents.
The age at onset in the parents was 53 and 51 years in
pedigree 1, 45 years in pedigree 5, and 39 years in ped-
igree 6. The age at initial onset in the children was 8
years in pedigree 1; 16 and 18 years in pedigree 5, with
an incidental asymptomatic identification; and 14 years
in pedigree 6, with an asymptomatic identification. The
symptoms included ischemic brain manifestations in
each of these children. Symptomatic heterogeneity was
observed in these families, and clinical anticipation—
that is, earlier age at onset in younger patients—
also was observed.Whether clinical anticipationwas due
to delayed diagnosis because of underdeveloped diag-
nostic tools or a poor standard of medicine or because
the same molecular phenomenon seen in CAG-repeat
disease (Takiyama et al. 1995) may occur in moyamoya
disease is not certain. The observation of both juvenile
and adult types in the same families strongly supports
the hypothesis that both types of moyamoya disease are
caused by the same genetic disorder.
The results of an extensive genetic study are not avail-
able, but the most likely pathogenesis of moyamoya dis-
ease is thought to be polygenic, on the basis of estimates
(Fukuyama et al. 1991) calculated by means of Ed-
wards’s (1960) hypothesis. However, the microsatellite
polymorphism D3S3050, mapped to chromosome
3p24.2-p26, showed strong evidence of linkage by non-
parametric analysis, with an NPL score of 3.46. Other
genes close to the linked region on chromosome 3p in-
clude the genes responsible for Marfan syndrome and
the von Hippel–Lindau disease gene (MIM 193300; La-
tif et al. 1993) responsible for hemangioblastoma,which
is a vascular tumor. Since the moyamoya disease gene
maps to this region of chromosome 3p and may encode
a gene product that is fundamentally important for the
formation and maintenance of vascular-wall homeosta-
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sis, this region of the genome is of great interest in the
study of inherited vascular disease. Eventual molecular
characterization of this disease may provide valuable
insights into the processes of progressive stenosis and
occlusion of the terminal portion of the internal carotid
artery and possibly may suggest a new therapeutic
method, such as gene therapy.
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